Sanger Institute Sequences Two Cancer Genomes on Illumina and SOLiD Platforms

The two papers indicate that whole-genome short-read sequencing technologies are becoming increasingly important for identifying cancer-causing genes that could eventually lead to better diagnosis and treatment.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.